Company intelligence / Profile preview

Guangzhou Zhongda Pharmaceutical Development

Guangzhou, Guangdong, China

Ownership: Private
Development stage: Other

Overview

Guangzhou Zhongda Pharmaceutical Development Co. Ltd. is involved in the research and integrative pharmacological evaluation of traditional Chinese medicinal products aimed at disease modulation (notably diabetes), using high-throughput chemical analysis and computational target prediction approaches. There are no indications this company has clinical-stage assets as of 2024[5].

Therapeutic areas: Endocrinology
Modalities: Small moleculeTraditional Chinese medicine
Industry: Biotech

Beyond the preview

Go deeper on Guangzhou Zhongda Pharmaceutical Development.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guangzhou Zhongda Pharmaceutical Development.

Explore the full profile